New opportunities to treat bowel cancer

Research in mice identifies new treatment options for one of the most common cancers

2013-07-08

(Press-News.org) Researchers have discovered the genetic processes that cause specific types of bowel cancer. Using this knowledge, they identified cancer drugs that target these genes. Their findings offer the opportunity to develop personalised treatment based on a person's genetic profile.

More than one million people develop bowel cancer each year, which is one of the most common causes of death in cancer patients. One in ten colon cancers are caused by mutations in the BRAF gene, a gene commonly associated with skin cancers. Although successful treatments against BRAF mutations in skin cancers have been developed, these treatments have not been effective against BRAF mutations in colon cancer.

"Our approach encapsulates the aim of cancer genomics: to discover changes to DNA responsible for cancer development and pinpoint the "Achilles heels" of cancer in order to identify new treatments," says Professor Roland Rad, lead author from the Technical University of Munich and the German Cancer Research Center. "Our studies in mice revealed how genes co-operate to cause a specific subset of colon cancers. We identified main players, the order in which they occur during tumour progression, and the molecular processes how they turn relatively benign cell growth into threatening cancers. Such processes are targets for new treatments."

The team looked at the development of BRAF associated bowel cancer in mice, replacing the normal gene with a version containing a mutation identical with that in human cancers. Mice with the mutated BRAF gene developed hyperplastic polyps – abnormal growth of cell bundles in their intestine wall. These polyps progressed from benign growths to malignant cancers.

In the mutant mice, the team uncovered a stepwise process of genetic alterations, which drive the development of this type of colon cancer. Some alterations activate genes such a BRAF, making them potentially cancerous. Others disrupt protective proteins such as p53, inactivating their ability to suppress cancer progression.

"Understanding the genetic makeup of different colorectal cancer subtypes will guide therapeutic decision making in the future" says Professor Allan Bradley, senior author from the Wellcome Trust Sanger Institute. "Our ability to engineer specific genetic alterations in mice allows us to study the function of cancer genes and to model specific cancer subtypes at an organismal level. Such mouse models are also invaluable for testing anticancer drugs before using them in clinical trials".

The team tested a wide range of existing and candidate drugs for their ability to slow down or prevent growth of mouse colon cancer and human colon cancer cells, finding several highly effective approaches. These were tested individually or in combination with one another to find the most powerful therapies.

Mice with the Braf-associated colon cancer had very similar therapeutic responses to those of BRAF-associated cancer cells from patients with colon cancer, highlighting the effectiveness of mice in preclinical cancer research.

The team found multiple drugs and drug combinations that were effective against human colon cancer cells. These are promising results for alternative second- or third-line treatments after resistance to the first round of treatment against this occurs.

"Our results illustrate the power of combining genomic information with large-scale drug screening to provide new targeted treatment strategies for patients with specific cancer subtypes," says Dr Ultan McDermott, author from the Wellcome Trust Sanger Institute.

### Notes to Editors Publication Details Roland Rad, Juan Cadiñanos, Lena Rad, et al (2013). 'A genetic progression model of BrafV600E-induced intestinal tumourigenesis reveals targets for therapeutic intervention'

Advanced online publication in Cancer Cell, 08 June 2013. DOI: 10.1016/j.ccr.2013.05.014

Funding The work was supported by the Wellcome Trust and the Helmholtz Gemeinschaft, Deutsche Forschungsgemeinschaft, FEBS, and International Human Frontiers Science Program Organization.

Participating Centres Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, 81675, München, Germany German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany Wellcome Trust Sanger Institute, Genome Campus, Hinxton/Cambridge CB10 1SA, UK Instituto de Medicina Oncológica y Molecular de Asturias (IMOMA), 33193 Oviedo, Spain Instituto de Biomedicina y Biotecnología de Cantabria, 39011 Santander, Spain Department of Pathology, Ludwig-Maximilians-Universität, 80337 München, Germany Department of Veterinary Medicine, University of Cambridge, CB3 0ES Cambridge, UK Instituto Universitario de Oncología, Universidad de Oviedo, 33006 Oviedo, Spain Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, 28049 Madrid, Spain School of Pathology and Laboratory Medicine, University of Western Australia, WA 6009, Australia

Selected Websites The Wellcome Trust Sanger Institute is one of the world's leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease. http://www.sanger.ac.uk

The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests. http://www.wellcome.ac.uk

Contact details Don Powell Media Manager
Wellcome Trust Sanger Institute
Hinxton, Cambridge, CB10 1SA, UK
Tel +44 (0)1223 496 928
Mobile +44 (0)7753 7753 97
Email press.office@sanger.ac.uk

ELSE PRESS RELEASES FROM THIS DATE:

Gunning for trouble: Study of young assault victims finds risky mix of gun possession and aggression

2013-07-08

ANN ARBOR, Mich. — They're young. They've been injured in an assault – so badly they went to the emergency room. And nearly one in four of them has a gun, probably an illegal one. What happens next? A new study by the University of Michigan Injury Center provides data that could be important to breaking the cycle of gun violence that kills more teens and young adults than anything except auto accidents. In the new issue of the journal Pediatrics, the team from the U-M Injury Center reports data from interviews with 689 teens and young adults who came to an emergency ...

Egg donation in European clinics: Why do women do it?

2013-07-08

London, 8 July 2013: Egg donation is now one of the major reasons why couples travel abroad for fertility treatment. Because this growing trend may circumvent regulations at home or raise concerns about financial inducement, it has also become one of the most controversial. Yet little is known about the women who provide the donor eggs in overseas clinics - their characteristics, their motivation and their compensation. A study performed by ESHRE, which surveyed (by questionnaire) 1423 egg donors at 60 clinics in 11 European countries, has now found that the majority ...

Adverse effects of phthalates on ovarian response to IVF

2013-07-08

London, 8 July 2013: Phthalates are among a group of industrial chemicals shown in some studies to have adverse effects on reproductive health and development, particularly in the male. As such, they have been collectively defined as "endocrine disruptors", and proposed as one of several possible environmental exposures responsible for a decline in fertility. They are classified in two groups - high molecular weight phthalates are used in the production of plastics, while low molecular weight phthalates are frequently used in the manufacture of cosmetics.(1) Human ...

Early life and in utero factors found to influence testicular function in adulthood

2013-07-08

London, 8 July 2013: Studies over the past 20 years have suggested (though not unequivocally confirmed) that semen quality is in decline, reflected most evidently in falling sperm counts and reduced sperm motility.(1) The explanations have been controversially attributed to environmental factors (such as exposure to toxins) and to male smoking. Now, a new study based on a 20-year follow-up of one of the world's largest study cohorts, suggests that exposure to several factors in utero and in early life may also lead to reduced semen parameters in adulthood - and potentially ...

IVF for 200 euro per cycle

2013-07-08

London -- A study performed in Belgium has shown that low-cost IVF for developing and poor resource countries is feasible and effective, with delivery rates not much different from those achieved in conventional IVF programmes. This proof-of-principle study, say the investigators, suggests that infertility care may now be "universally accessible"."We showed that the IVF methodology can be significantly simplified and result in successful outcomes at levels that compare favourably to those obtained in high resource programs," they note. "We estimate that the cost of our ...

Research finds people with depression tend to pursue generalized goals

2013-07-08

Researchers from the University of Liverpool have found that people with depression have more generalised personal goals than non-depressed people. A study conducted by Dr Joanne Dickson, in the University's Institute of Psychology, Health and Society, analysed the lists of personal goals made by people who suffered with depression and those who didn't. The participants were asked to list goals they would like to achieve at any time in the short, medium or long-term. The goals were categorised for their specificity – for example a global or abstract goal such as, 'to ...

Cosmic dust belts without dust

2013-07-08

Planets and asteroids, red giants and brown dwarfs -- there are all kinds of objects in our Universe. Debris disks are among them. These are belts consisting of countless dust particles and planetesimals, circling around one central star. "At least one fifth of stars are surrounded by dust belts like these," Prof. Dr. Alexander Krivov from the Friedrich-Schiller-University Jena explains. "They are the remains of the formation of planets, in which the unused, building materials are collected," the astrophysicist points out. Therefore debris disks are an important piece in ...

Tailoring diabetes treatment to older patients yields dramatic results

2013-07-08

More than a quarter of over 70s with type 2 diabetes could benefit simply from improving communication and education in the clinic, new research has revealed. A study led by the University of Exeter Medical School and published in The Lancet found that 27 percent achieved better glycaemic control through individualised care alone. At the moment, patients over the age of 70 are treated using a blanket method of aggressively reducing blood glucose levels, but that does little to take their complex needs into account. Dr David Strain, from the University of Exeter Medical ...

Less haze in Singapore as the cause becomes clearer and more complex

2013-07-08

Small and large-scale farmers in Riau province, Sumatra, have been blamed for the recent choking smoke smothering Singapore and parts of Malaysia. But scientists in Indonesia have added a third category of 'mid-level entrepreneurs'. These entrepreneurs buy unregulated access to land for oil palm and clear it by burning, seemingly unrestrained by government. Scientists at the World Agroforestry Centre, who have been studying land conversion in Sumatra, say they have identified this third group of local land investors who operate outside the government system, making them ...

New anti-cancer compound shows promise for breast cancer

2013-07-08

VIDEO: Researchers from the Walter and Eliza Hall Institute in Melbourne, Australia, have discovered that anti-cancer compounds currently in clinical trials for some types of leukemia could offer hope for treating... Click here for more information. Melbourne researchers have discovered that anti-cancer compounds currently in clinical trials for some types of leukaemia could offer hope for treating the most common type of breast cancer. The researchers, from the Walter ...

One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes

One of the largest studies of its kind finds early intervention with iron delivered intravenously during pregnancy is a safe and effective treatment for anemia

[Press-News.org] New opportunities to treat bowel cancer
Research in mice identifies new treatment options for one of the most common cancers

New opportunities to treat bowel cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: